Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Check out various ways to earn online income from home. Start today to enhance your financial situation.
16,071 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Search interest in the phrase bitcoin dead has surged to fresh highs, sparking questions about whether investors are ...
Gen Z is pushing a rebound in vinyl records and print media, shaping the market while stretching household budgets. T...
Greycroft increased its Sportradar stake in a year where the stock fell sharply, illustrating how big investors respo...
Fox Factory's Q4 2025 results shed light on demand for high-performance suspensions and the company’s margin discipli...
BigBear.AI released its latest quarterly results after the bell, showing a sharp balance-sheet improvement and a path...
When a beverage maker expands beyond a single hero brand, the investment narrative changes. Celsius transformed its g...
When Space Force makes obvious moves to pause launches from Boeing and Lockheed's space venture, investors face a tes...
As markets pivot in March 2026, traders are reassessing broker choices. This report highlights the best e*trade alter...
TeraWulf (WULF) shares pull back 22% from their 52-week high, but the company’s expanding HPC footprint and Google-ba...
A sharp rise in tiny USDT transfers on Ethereum has sparked warnings for users after a network upgrade. Analysts say ...
Amazon expands its delivery options by adding a paid three-hour window, changing Prime perks and costs for millions o...